{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:38:01Z","timestamp":1792881481342,"version":"4.5.0"},"reference-count":31,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","issue":"03","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Bras Ginecol Obstet"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Objective\u2003To analyze whether acetylsalicylic (ASA) intake modifies the mean uterine arteries pulsatility index (UtA-PI) at the 2nd or 3rd trimester in a cohort of pregnant women with abnormal mean UtA-PI at between 11 and 14 weeks of gestation.<\/jats:p><jats:p>\n          Methods\u2003This is a retrospective cohort study. Singleton pregnancies with abnormal mean UtA-PI at between 11 and 14 weeks of gestation were studied. The participants were divided into 3 groups: 1) If the participant did not take ASA during pregnancy; 2) If the participant took ASA before 14 weeks of gestation; and 3) If the participant took ASA after 14 weeks of gestation. The mean UtA-PI was evaluated at the 2nd and 3rd trimesters, and it was considered to improve when it decreased below the 95th percentile. The prevalence ratio (PR) and the number needed to treat (NNT) were calculated.<\/jats:p><jats:p>\n          Results\u2003A total of 72 participants with a mean UtA-PI\u2009&gt;\u200995th percentile at the 1st trimester of gestation were evaluated. Out of the 18 participants who took ASA, 8 participants started it before 14 weeks of gestation and 10 after. A total of 33.3% of these participants had improved the mean UtA-PI at the 2nd and 3rd trimesters of gestation, although it was not statistically significant (p\u2009=\u20090.154). The prevalence ratio was 0.95 (95% confidence interval [CI]: 0.31\u20131.89), but between the 1st and 2nd trimesters of gestation, the PR was 0.92 (95%CI: 0.21\u20130.99) and it was statistically significant.<\/jats:p><jats:p>\n          Conclusion\u2003The present work demonstrates a modification of the mean UtA-PI in participants who took ASA compared with those who did not. It is important to check if ASA can modify the normal limits of uterine arteries because this could have an impact on surveillance.<\/jats:p>","DOI":"10.1055\/s-0042-1742411","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T23:53:28Z","timestamp":1644450808000},"page":"231-237","source":"Crossref","is-referenced-by-count":3,"title":["Could Aspirin Treatment Modify the Assessment of the Uterine Arteries?"],"prefix":"10.61622","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-0428","authenticated-orcid":false,"given":"Gabriela Marisol","family":"Vallejo","sequence":"additional","affiliation":[{"name":"Universidad El Bosque, El Bosque Research Group of Maternal Fetal, Medicine and Gynecology, Ecodiagn\u00f3stico El Bosque SAS, Los Cobos Medical Center, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-8633","authenticated-orcid":false,"given":"Montserrat","family":"Uriel","sequence":"additional","affiliation":[{"name":"Universidad El Bosque, El Bosque Research Group of Maternal Fetal, Medicine and Gynecology, Ecodiagn\u00f3stico El Bosque SAS, Los Cobos Medical Center, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-1388","authenticated-orcid":false,"given":"Alexandra","family":"Porras-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Research Group Community Medicine and Collective Health, El Bosque University, Los Cobos Medical Center, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7040-2705","authenticated-orcid":false,"given":"Ximena Carolina","family":"Romero","sequence":"additional","affiliation":[{"name":"Universidad El Bosque, El Bosque Research Group of Maternal Fetal, Medicine and Gynecology, Ecodiagn\u00f3stico El Bosque SAS, Los Cobos Medical Center, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","article-title":"Maternal morbidity associated with early-onset and late-onset preeclampsia","volume":"124","author":"S Lisonkova","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.15446\/revfacmed.v68n4.79702","article-title":"Risk factors for preterm birth in Bogot\u00e1, D.C., Colombia","volume":"68","author":"J S Ahumada","year":"2020","journal-title":"Rev Fac Med (Caracas)"},{"issue":"01","key":"ref3","first-page":"000105","article-title":"Reality of preeclampsia in Colombian pregnant women","volume":"1","author":"M Uriel","year":"2016","journal-title":"J Gynecol"},{"issue":"02","key":"ref4","first-page":"21","article-title":"Incidence of hypertensive disorders in pregnancy and clinical-demographic characteristics in pregnant women in three institutions in Bogot\u00e1, D.C., Colombia","volume":"20","author":"X C Romero","year":"2018","journal-title":"Investig Segur Soc Salud."},{"issue":"03","key":"ref5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18597\/rcog.3075","article-title":"Expectant management in non-severe pre-eclampsia, obstetric and perinatal outcomes in a high complexity hospital in Neiva (Colombia)","volume":"69","author":"Y N Guzm\u00e1n-Yara","year":"2018","journal-title":"Colomb J Obstet Gynecol"},{"issue":"03","key":"ref6","first-page":"289","article-title":"[Clinical practice guidelines for approaching pregnancy-associated hypertensive complications]. Colomb J","volume":"64","author":"G Buitrago-Guti\u00e9rrez","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref7","first-page":"245","article-title":"[Clinical practice guidelines for the prevention and early detection of pregnancy disorders]. Colomb J","volume":"64","author":"J Amaya-Gu\u00edo","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: updates in pathogenesis, definitions, and guidelines","volume":"11","author":"E Phipps","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"04","key":"ref9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/uog.17351","article-title":"Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14\u2009weeks: a randomized controlled study","volume":"49","author":"E Scazzocchio","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/0029-7844(95)00020-r","article-title":"Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed","volume":"85","author":"S Lin","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.0960-7692.2001.00572.x","article-title":"Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation","volume":"18","author":"A T Papageorghiou","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"05","key":"ref12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/uog.7439","article-title":"Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks","volume":"34","author":"L C Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"06","key":"ref13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"N O'Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"01","key":"ref14","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"N O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"D L Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"01","key":"ref16","doi-asserted-by":"publisher","first-page":"87.e1","DOI":"10.1016\/j.ajog.2016.02.016","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation","volume":"215","author":"A Tsiakkas","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"05","key":"ref17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s13224-017-1058-4","article-title":"Role of aspirin in high pulsatility index of uterine artery: a consort study","volume":"68","author":"N Sharma","year":"2018","journal-title":"J Obstet Gynaecol India"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"L M Askie","year":"2007","journal-title":"Lancet"},{"issue":"07","key":"ref19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"D L Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"ref20","first-page":"41","volume-title":"Physiopathology","author":"G Tonni","year":"2019"},{"issue":"09","key":"ref21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S1701-2163(16)34300-6","article-title":"Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis","volume":"31","author":"E Bujold","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"issue":"02","key":"ref22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/uog.12371","article-title":"ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics","volume":"41","author":"A Bhide","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"01","key":"ref23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"A Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"02","key":"ref24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/uog.5402","article-title":"Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia","volume":"32","author":"W Plasencia","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"06","key":"ref25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1046\/j.0960-7692.2001.00594.x","article-title":"Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation","volume":"18","author":"A M Martin","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"02","key":"ref26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"O G\u00f3mez","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"06","key":"ref27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1590\/S0034-89102008000600003","article-title":"Methods for estimating prevalence ratios in cross-sectional studies","volume":"42","author":"L M Coutinho","year":"2008","journal-title":"Rev Saude Publica"},{"issue":"07","key":"ref28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/oem.2007.034777","article-title":"Approaches for estimating prevalence ratios","volume":"65","author":"J A Deddens","year":"2008","journal-title":"Occup Environ Med"},{"issue":"01","key":"ref29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/s0213-9111(03)71694-x","article-title":"[Odds ratio or prevalence ratio? Their use in cross-sectional studies]","volume":"17","author":"A Schiaffino","year":"2003","journal-title":"Gac Sanit"},{"issue":"04","key":"ref30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/oem.55.4.272","article-title":"Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done?","volume":"55","author":"M L Thompson","year":"1998","journal-title":"Occup Environ Med"},{"issue":"05","key":"ref33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/uog.6215","article-title":"Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study","volume":"32","author":"M Haapsamo","year":"2008","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/article\/could-aspirin-treatment-modify-the-assessment-of-the-uterine-arteries\/","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1742411.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T20:57:15Z","timestamp":1721336235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/could-aspirin-treatment-modify-the-assessment-of-the-uterine-arteries\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":31,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,5,16]]},"published-print":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1742411","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}